Clinical Trials 0 COMMENT 29 Views Results from LIDDS’ preclinical study Malin Otmani August 14, 2018 The Swedish company has announced …
Clinical Trials 0 COMMENT 22 Views Update on Cantargia’s CANFOUR trial Malin Otmani August 13, 2018 The company announces the status …
Clinical Trials 0 COMMENT 31 Views New data from Bavarian Nordic Malin Otmani August 9, 2018 The company announces results from …
Clinical Trials 0 COMMENT 34 Views Lundbeck’s new treatment of Parkinsons into clinical development Malin Otmani August 8, 2018 The company begins clinical development …
Clinical Trials 42 Views Bavarian Nordic initiates Phase 2 trial Malin Otmani July 24, 2018 The first patient has been …
Clinical Trials 36 Views Positive results from A1M Pharma Malin Otmani July 24, 2018 The company has reported positive …
Clinical Trials 163 Views Oncopeptide update clinical trial Malin Otmani June 27, 2018 Oncopeptides present updated interim data …
Clinical Trials 174 Views AstraZeneca discontinues Alzheimer trials Malin Otmani June 25, 2018 AstraZeneca and Eli Lilly and …
Clinical Trials 197 Views Follicum’s hair growth study fully recruited Malin Otmani June 19, 2018 Follicum announces that all patients …
Clinical Trials 222 Views Positive results from Lundbeck trial Malin Otmani June 15, 2018 H. Lundbeck A/S and Takeda …
Clinical Trials 161 Views Positive EU opinion for Lundbeck Malin Otmani June 7, 2018 Lundbeck and Otsuka Pharmaceutical announce …
Clinical Trials 178 Views Headline results from Novo Nordisk’s Pioneer trial Malin Otmani June 7, 2018 The company has anounced results …
Clinical Trials 206 Views AstraZeneca and MSD present new results about Lynparza Malin Otmani June 7, 2018 The two pharma giants reports …
Clinical Trials 214 Views Nordic Nanovector’s Paradigme trial approved to start Malin Otmani May 30, 2018 The Phase 2b trial with …
Clinical Trials 236 Views AstraZeneca’s TERRANOVA trial has not met the primary endpoint Malin Otmani May 30, 2018 The trial, the second of …
Clinical Trials 192 Views Zealand Pharma completes Phase 3 trial with dasiglucagon Malin Otmani May 29, 2018 All subjects have been enrolled …
